腸道菌轉譯研究工具的運用

Tools for Gut Microbiome Translational Research

10.6320/FJM.202203_26(2).0001

吳偉愷(Wei-Kai Wu)

腸道菌 ； 轉譯醫學 ； 多體學 ； 培養體學 ； 代謝體學 ； 無菌鼠 ； gut microbiota ； translational medicine ； multiomics ； culturomics ； metabolomics ； germ-free mice

台灣醫學

26卷2期（2022 / 03 / 25）

137 - 142

繁體中文

腸道菌已被視為是一個系統性的動態內分泌器官，廣泛調控人體免疫、代謝與神經傳遞功能。然而腸道菌的組成、功能以及與人體交互作用十分複雜，許多機制尚未清楚，需要進一步研究釐清腸道菌調控人類病生理的關鍵路徑，才能加速進入臨床應用階段。過去由於次世代定序的普及，發現人體腸道菌與許多慢性疾病有顯著關聯性，近年整合多體學分析、厭氧菌培養分離技術、無菌定植小鼠模式、微生物代謝體等轉譯研究工具的發展，腸道菌與疾病的因果性和機制探討逐漸成為顯學。本文旨在介紹常見腸道菌轉譯研究工具的整合與運用，期望有助於促進國內人類腸道菌的研究進展。

Gut microbiota have been regarded as a dynamic endocrine organ which systemically regulate immunity, metabolism, and neurological function of the human body. However, the gut microbiota composition, function as well as its interactions with the human body is a complex ecosystem in which many mechanisms remain unclear. Further investigations are required to facilitate microbiome research into clinical application by elucidating essential host-microbe pathways responsible for human pathophysiology regulation. In the past years, associations between the human gut microbiota and many chronic diseases were revealed by taking advantage of the next generation sequencing technology. Recently, investigations on the causality and mechanisms of gut microbiome are accumulating through the integration of translational tools such as multi-omics analysis, anaerobic culturomics, gnotobiotic mice models and microbiota-based metabolomics. The aim of this perspective review is to introduce the integration and application of common gut microbiome translational tools, hopefully, to promote domestic research progress in the field of human microbiome.

1. Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med 2016;375:2369-79.
   連結：
2. Ruff WE, Greiling TM, Kriegel MA. Host-microbiota interactions in immune-mediated diseases. Nat Rev Microbiol 2020;18:521-38.
   連結：
3. Sonnenburg ED, Sonnenburg JL. The ancestral and industrialized gut microbiota and implications for human health. Nat Rev Microbiol 2019;17:383-90.
   連結：
4. Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 2021;19:55-71.
   連結：
5. Eisenstein M. The hunt for a healthy microbiome. Nature 2020;577:S6-S8.
   連結：
6. Wu WK, Chen CC, Panyod S, et al. Optimization of fecal sample processing for microbiome study - The journey from bathroom to bench. J Formos Med Assoc 2019;118:545-55.
   連結：
7. Integrative HMPRNC. The integrative human microbiome project. Nature 2019;569:641-8.
   連結：
8. Martinez N, Hidalgo-Cantabrana C, Delgado S, et al. Filling the gap between collection, transport and storage of the human gut microbiota. Sci Rep 2019;9:8327.
   連結：
9. Johnson JS, Spakowicz DJ, Hong BY, et al. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat Commun 2019;10:5029.
   連結：
10. Mallick H, Ma S, Franzosa EA, et al. Experimental design and quantitative analysis of microbial community multiomics. Genome Biol 2017;18:228.
    連結：
11. Zhou W, Sailani MR, Contrepois K, et al. Longitudinal multi-omics of host-microbe dynamics in prediabetes. Nature 2019;569:663-71.
    連結：
12. Lloyd-Price J, Arze C, Ananthakrishnan AN, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 2019;569:655-62.
    連結：
13. Lagier JC, Dubourg G, Million M, et al. Culturing the human microbiota and culturomics. Nat Rev Microbiol 2018;16:540-50.
    連結：
14. Round JL, Palm NW. Causal effects of the microbiota on immune-mediated diseases. Sci Immunol 2018;3: eaao1603.
    連結：
15. Kennedy EA, King KY, Baldridge MT. Mouse microbiota models: Comparing germ-free mice and antibiotics treatment as tools for modifying gut bacteria. Front Physiol 2018;9:1534.
    連結：
16. Wu WK, Hsu CC, Sheen LY, et al. Measurement of gut microbial metabolites in cardiometabolic health and translational research. Rapid Commun Mass Spectrom 2020;34(Suppl 1):e8537.
    連結：
17. Han S, Van Treuren W, Fischer CR, et al. A metabolomics pipeline for the mechanistic interrogation of the gut microbiome. Nature 2021;595:415-20.
    連結：
18. Hsu YL, Chen CC, Lin YT, et al. Evaluation and optimization of sample handling methods for quantification of short-chain fatty acids in human fecal samples by GC-MS. J Proteome Res 2019;18:1948-57.
    連結：
19. Liao HY, Wang CY, Lee CH, et al. Development of an efficient and sensitive chemical derivatization-based LC-MS/MS method for quantifying gut microbiota-derived metabolites in human plasma and its application in studying cardiovascular disease. J Proteome Res 2021;20:3508-18.
    連結：
20. Koh A, Backhed F. From association to causality: The role of the gut microbiota and its functional products on host metabolism. Mol Cell 2020;78:584-96.
    連結：